Track Psychemedics's total revenue ($20M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2024
Trailing 12 months ending Dec 2024
As of the most recent data (December 2024), PMD shows a total revenue of $20M. That compares with $22M in the prior-year period — down 10.9% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PMD's total revenue is now $20M (was $22M) — a 10.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Psychemedics is outperforming or lagging.
The Healthcare sector average total revenue is about $110B. Psychemedics is at $20M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how PMD stacks up against individual peers as well.
Tracking PMD's total revenue over time shows whether Psychemedics is scaling, shrinking, or reshaping that part of the business. The current reading is $20M That compares with $22M in the prior-year period — down 10.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total revenue page, Stockcircle has Psychemedics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $20M) with ownership activity and broader fundamentals.